Skip to main content
Clinical Trials/IRCT2015101522173N2
IRCT2015101522173N2
Completed
Phase 2

Evaluation of comparison between Remifentanil infusion and single dose intravenous Hydralazine + Propranolol administration to provide controlled hypotension in patients undergoing Rhino plastic surgery in khalili hospital during 2014-2015

Shiraz University of Medical Sciences0 sites80 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Hypertension.
Sponsor
Shiraz University of Medical Sciences
Enrollment
80
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
8 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Inclusion criterion: all patients in the range of 20\-40 years old with class I ASA.
  • Exclusion criteria: patients in class II \& III ASA; recent (the last 3 months) general anesthesia record; drug abuse; history of allergy to Propranolol or Hydralazine or Remifentanil; high blood pressure; cardiovascular diseases should be eliminated.

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials